Clinical Trial Update: Percutaneous Electroneurostimulation of Dermatome T6 for Appetite Reduction and Weight Loss in Morbidly Obese Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated percutaneous electroneurostimulation of dermatome T6 for appetite reduction and weight loss in morbidly obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Hospital General Universitario Elche | Conditions: Appetite Reduction, Weight Loss | NA | Status: COMPLETED